GrayBug to Present at the 6th Annual Conference of the Arnold and Mabel Beckman Initiative for Macular Research


January 9, 2014 – GrayBug is pleased to announce that it has been invited to present at the 6th Annual conference of the Arnold and Mabel Beckman Initiative for Macular Research (BIMR) at the Beckman Center of the National Academies of Science and Engineering on January 23-25, 2014, in Irvine, CA.

About the BIMR

Through a generous grant from the Arnold and Mabel Beckman Foundation, the Beckman Initiative for Macular Research (BIMR) brings together outstanding scientists, engineers, medical researchers, and clinicians — all focused on a common goal: developing a better understanding of atrophic macular degeneration.

Related News

Press release

Graybug Vision CEO to Participate in OIS@ASRS Conference

– Company to Discuss Upcoming Phase 1/2 Study of Twice Per Year Treatment for AMD – Redwood City, CA – August 8, 2017 – Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially Read more…

Press release

Valerie Smith Joins Graybug Vision as VP, Global Clinical Development Operations

Redwood City, CA – May 8, 2017 – Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases including wet age-related macular degeneration (AMD) and glaucoma, today announced that Read more…

Press release

Graybug Vision’s Potential Once-Per-Year AMD Treatment Data Presented at ARVO 2017

– Company Developing Injectable Products for Treating Glaucoma and AMD – Redwood City, CA – May 8, 2017 – Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases Read more…